Clinical Trials
5
Active:0
Completed:4
Trial Phases
2 Phases
Phase 3:4
Phase 4:1
Drug Approvals
4
HSA:4
Drug Approvals
TRAZHER (Trastuzumab) Powder for Concentrate for Solution for Infusion 420mg/vial
- Approval Date
- Nov 22, 2023
HSA
TRAZHER (Trastuzumab) Powder for Concentrate for Solution for Infusion 150mg/vial
- Approval Date
- Oct 19, 2022
HSA
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 3
4 (80.0%)Phase 4
1 (20.0%)Efficacy and Safety of Hypertonic Sodium Lactate Solution Compared With 6% HES Solution in CABG Patients
Phase 4
Completed
- Conditions
- Coronary Heart Disease
- Interventions
- Drug: Hypertonic sodium lactateDrug: 6% Hydroxy Ethyl Starch
- First Posted Date
- 2012-08-01
- Last Posted Date
- 2012-08-01
- Lead Sponsor
- Innogene Kalbiotech Pte. Ltd
- Target Recruit Count
- 100
- Registration Number
- NCT01654653
- Locations
- 🇮🇩
National Cardiovascular Center Harapan Kita, Jakarta, Indonesia
Efficacy, Safety of Solution Containing Hyperosmolar Sodium Lactate Infusion for Resuscitation of Patients With Hemorrhagic Shock
Phase 3
Completed
- Conditions
- Hemorrhagic Shock
- Interventions
- Drug: Hyperosmolar sodium lactateDrug: Ringer's lactate
- First Posted Date
- 2011-09-13
- Last Posted Date
- 2011-09-13
- Lead Sponsor
- Innogene Kalbiotech Pte. Ltd
- Target Recruit Count
- 71
- Registration Number
- NCT01433276
- Locations
- 🇮🇩
Department of Surgery, Dr. Hasan Sadikin Hospital, Bandung, Indonesia
Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS)
Phase 3
- Conditions
- Dengue Shock Syndrome
- Interventions
- Drug: Ringer's lactateDrug: Hypertonic sodium lactate
- First Posted Date
- 2009-08-27
- Last Posted Date
- 2009-08-28
- Lead Sponsor
- Innogene Kalbiotech Pte. Ltd
- Target Recruit Count
- 50
- Registration Number
- NCT00966628
- Locations
- 🇮🇩
Hasan Sadikin Hospital, Dept. of Pediatrics, Bandung, West Java, Indonesia
Efficacy, Safety of Hypertonic Lactate Soln. as Fluid Resuscitation Compared With Ringer's Lactate in Post-CABG Pats
Phase 3
Completed
- Conditions
- Low Cardiac Output
- Interventions
- Drug: Hypertonic lactateDrug: Ringer's lactate
- First Posted Date
- 2007-09-14
- Last Posted Date
- 2007-09-14
- Lead Sponsor
- Innogene Kalbiotech Pte. Ltd
- Target Recruit Count
- 230
- Registration Number
- NCT00529490
- Locations
- 🇮🇩
National Cardiac Center, Department of Surgery and Intensive Care Unit, Harapan Kita Hospital, Jakarta, Indonesia
The Efficacy of Hypertonic Lactate Solution in CABG(Coronary Artery Bypass Grafting) Patients
Phase 3
Completed
- Conditions
- Low Cardiac Output
- Interventions
- Drug: Hypertonic lactateDrug: Ringer's lactate
- First Posted Date
- 2007-09-14
- Last Posted Date
- 2007-09-14
- Lead Sponsor
- Innogene Kalbiotech Pte. Ltd
- Target Recruit Count
- 66
- Registration Number
- NCT00529711
- Locations
- 🇮🇩
National Cardiac Center, Department of Surgery and Intensive Care Unit, Harapan Kita Hospital, Jakarta, Indonesia
News
No news found